Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |  Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 480Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
Perspectives in Clinical Research

Submit your manuscripts

  • Online submission
  • Wider visibility though open access
  • Higher impact with wider visibility
  • Prompt review

Submit article online

 

Pubmed

April-June 2020 | Vol 11 | Issue  2 Table ofContents RSS Feed
Editorial
Recruitment and retention of participants in clinical studies: Critical issues and challenges
Mira Desai
A key determinant of a successful clinical study is to efficiently recruit and retain an adequate number of the study population. However, worldwide the clinical trial professionals experience press...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
 
Review Article
Exploring digital therapeutics: The next paradigm of modern health-care industry
Raj Khirasaria, Vikramjit Singh, Angelika Batta
In this era of 21st century, the most valuable resource is data. Digital technology can generate terabytes of data which has a tremendous potential in the modern-day world. Pharmaceutical...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
 
Opinion
Clinical trials during the COVID-19 pandemic: Challenges of putting scientific and ethical principles into practice
Arun Bhatt
Global pandemic of COVID-19 is a serious unmet medical need requiring clinical research into effective therapies. Clinical trials during pandemics of infections face complex challenges of putting sc...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
 
Investigator Insights
Recruitment and retention of the participants in clinical trials: Challenges and solutions
Nayan Chaudhari, Renju Ravi, Nithya J Gogtay, Urmila M Thatte
Drug development is a tedious and expensive procedure and it takes roughly 10 to 15 years to take a potential treatment from bench to bedside and costs the pharmaceutical companies as much as USD ~2...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]

Read more articles....